Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
25.22
+1.38 (5.79%)
At close: Jan 16, 2026, 4:00 PM EST
25.25
+0.03 (0.12%)
After-hours: Jan 16, 2026, 5:38 PM EST
Oculis Holding AG Employees
Oculis Holding AG had 49 employees as of December 31, 2024. The number of employees increased by 13 or 36.11% compared to the previous year.
Employees
49
Change (1Y)
13
Growth (1Y)
36.11%
Revenue / Employee
$20,245
Profits / Employee
-$2,664,287
Market Cap
1.46B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 49 | 13 | 36.11% |
| Dec 31, 2023 | 36 | 8 | 28.57% |
| Dec 31, 2022 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OCS News
- 2 days ago - Oculis Holding AG (OCS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 10 days ago - Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference - GlobeNewsWire
- 12 days ago - Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis - GlobeNewsWire
- 5 weeks ago - Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewsWire
- 2 months ago - Oculis Reports Q3 2025 Financial Results and Provides Company Update - GlobeNewsWire
- 2 months ago - Oculis to Participate in Upcoming November Investor Conferences - GlobeNewsWire
- 2 months ago - Oculis Announces Oversubscribed $110 Million Financing to Accelerate Privosegtor Development - GlobeNewsWire
- 3 months ago - Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025 - GlobeNewsWire